A conference call to discuss PAREXEL's acquisition of APEX and updated financial outlook will begin at 10:00 a.m. EDT tomorrow, Thursday, September 27th and will be broadcast live over the Internet via webcast. The webcast may be accessed in the "Webcasts" portion of the Investor Relations section of the Company's website at http://www.PAREXEL.com. Users should follow the instructions provided to assure that the necessary audio applications are downloaded and installed. A replay of this webcast will be archived on the website approximately two hours after the call and will continue to be accessible for approximately one year following the live event. To participate via telephone, dial (612) 288-0329 and ask to join the PAREXEL Earnings Guidance conference call.
PAREXEL International Corporation is a leading global
bio/pharmaceutical services organization, providing a broad range of
knowledge-based contract research, medical communications and consulting
services to the worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite time-to-market
and peak-market penetration, PAREXEL has developed significant expertise
across the development and commercialization continuum, from drug
development and regulatory consulting to clinical pharmacology, clinical
trials management, medic
|SOURCE PAREXEL International Corporation|
Copyright©2007 PR Newswire.
All rights reserved